| Felix Spiegel, MD | |
|
5373 W Alabama St, Suite 121, Houston, TX 77056-5930 | |
| (713) 960-0003 | |
| (713) 960-0004 |
| Full Name | Felix Spiegel |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 35 Years |
| Location | 5373 W Alabama St, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013051960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP0504X | Podiatrist - Public Medicine | L2673 (Texas) | Secondary |
| 208600000X | Surgery | L2673 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Memorial City Hospital | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
Shire plc has announced that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment for Gaucher's disease patients, it has filed a treatment protocol for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Gaucher's disease.
Smokefree Innotec, Inc. announced today that it has received its first order from LTI News in Argentina and will fulfill the order within the next few days. LTI News will be placing the 'REAL Smokefree' product at strategic key locations in Buenos Aires as part of its initial sales and marketing campaign.
PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.
Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.
› Verified 3 days ago
| Provider Name | Memorial Hermann Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Shire plc has announced that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment for Gaucher's disease patients, it has filed a treatment protocol for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Gaucher's disease.
Smokefree Innotec, Inc. announced today that it has received its first order from LTI News in Argentina and will fulfill the order within the next few days. LTI News will be placing the 'REAL Smokefree' product at strategic key locations in Buenos Aires as part of its initial sales and marketing campaign.
PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.
Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Felix Spiegel, MD 5203 Fieldwood Dr, Houston, TX 77056-2705 Ph: (713) 960-0003 | Felix Spiegel, MD 5373 W Alabama St, Suite 121, Houston, TX 77056-5930 Ph: (713) 960-0003 |
News Archive
Shire plc has announced that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment for Gaucher's disease patients, it has filed a treatment protocol for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Gaucher's disease.
Smokefree Innotec, Inc. announced today that it has received its first order from LTI News in Argentina and will fulfill the order within the next few days. LTI News will be placing the 'REAL Smokefree' product at strategic key locations in Buenos Aires as part of its initial sales and marketing campaign.
PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.
Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.
› Verified 3 days ago